Results 1 to 5 of 11

Sound the alarm?—The Supreme Court’s renewed interest in life sciences patents could create additional hurdles across the field

USA - November 16 2012 First, there was Mayo v. Prometheus, where the Supreme Court found the medical diagnostic methods at issue were not patentable subject matter.

Rachel Krevans, Michael R. Ward

Northern District of California: 101 Roundup

USA - May 20 2022 In April 2022, judges in the Northern District of California issued several interesting decisions on Patent Subject Matter Eligibility under 35 U.S.C…

Berkeley G. Fife, Chris Han

MoFo IP newsletter

European Union, United Kingdom, USA - November 28 2016 On October 6, 2016, the FDA issued a final rule implementing certain provisions of the Medicare Prescription Drug, Improvement, and Modernization Act…

Paul Goldstein, Matthew M. D'Amore, David C. Doyle, Steve Keane, Joyce Liou, Alistair Maughan, Susan McLean, Dina Roumiantseva

European Patent Office finds plants and plant products patent-eligible

European Union - April 1 2015 On March 25, the Enlarged Board of Appeal (EBA) of the European Patent Office (EPO) handed a victory to those seeking to protect plant inventions in…

Michael R. Ward

Patent exhaustion and self-replicating technologies

USA - September 6 2012 In Bowman v. Monsanto, the Supreme Court requested the opinion of the Solicitor General on whether to grant review on two questions: “Whether the Federal Circuit erred by (1) refusing to find patent exhaustion in patented seeds even after an authorized sale and by (2) creating an exception to the doctrine of patent exhaustion for self-replicating technologies?”

Rachel Krevans, Michael R. Ward